Biofrontera Inc. (BFRI)
NASDAQ: BFRI
· Real-Time Price · USD
0.57
-0.04 (-6.59%)
At close: May 30, 2025, 3:59 PM
0.60
5.63%
After-hours: May 30, 2025, 05:40 PM EDT
-6.59% (1D)
| Bid | 0.56 |
| Market Cap | 5.37M |
| Revenue (ttm) | 37.99M |
| Net Income (ttm) | -11.53M |
| EPS (ttm) | -0.81 |
| PE Ratio (ttm) | -0.7 |
| Forward PE | -1.04 |
| Analyst | Buy |
| Ask | 0.64 |
| Volume | 168,367 |
| Avg. Volume (20D) | 114,391 |
| Open | 0.60 |
| Previous Close | 0.61 |
| Day's Range | 0.54 - 0.61 |
| 52-Week Range | 0.54 - 2.22 |
| Beta | 0.38 |
About BFRI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BFRI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BFRI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-16.5%
Biofrontera shares are trading lower after the com...
Unlock content with
Pro Subscription
4 months ago
+6.31%
Biofrontera shares are trading higher after the company announced the last patient completed the 1 year follow-up of study ALA-BCC-CT013 in December 2024.
3 weeks ago · accessnewswire.com
Biofrontera Inc. to Report First Quarter FY 2025 Financial Results on May 15, 2025WOBURN, MA / ACCESS Newswire / May 6, 2025 / Biofrontera Inc. (Nasdaq:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the commercialization of dermatological produc...
